Oxurion to participate in upcoming investor meetings

Leuven, be, boston, ma, us – march 8, 2021 – 08.00 am cet – oxurion nv (euronext brussels: oxur), a biopharmaceutical company developing next generation standard-of-care ophthalmic therapies, with a clinical stage portfolio in diabetic eye disease, today announces its management will participate and meet with investors at the following upcoming virtual meetings in march:            · h.c. wainwright global life sciences conference - march 9-10, 2021  pre-recorded company presentation, featuring tom graney, cfa, cfo to be made live on march 9 at 7:00 am est.the presentation will be available in the events section of oxurion's website at www.oxurion.com.a replay will be available for approximately 90 days following the conference.
BCYC Ratings Summary
BCYC Quant Ranking